AzTrials
AzTrials

Occupational HealthSFA-ImpactNCT07177014

Impact of Stress First Aid for Workers in Substance Misuse Settings

A study testing Stress First Aid (SFA) in people with Occupational Health, run by University of Texas at Austin at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Test the effectiveness of SFA adapted for the substance use outreach workforce compared to a no treatment control condition on social-support and burnout of HRWs in a cluster-randomized hybrid type I trial. Read more about this study

Who is it for?
Ages 18 to 100 years
Conditions the study is for
Occupational Health
What is being tested?
Stress First Aid (SFA)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteUnited States
Study dates
5 Dec 2025to 28 Feb 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • At least 18 years of age
  • In a paid or volunteer role as a substance use outreach worker or community health/outreach worker (whose work includes substance use outreach) with people who use drugs within TX, LA, AR, OK, NM and tribal areas
  • Able and willing to provide informed consent

Who cannot join

  • Inability to provide consent

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Project Coordinator contact

512-495-5277

SFA@austin.utexas.edu

Outreach Coordinator contact

SFA@austin.utexas.edu

United States1 site, 1 recruiting
  • The University of Texas at Austin

    Austin, Texas, 78712

    Recruiting

Other trials in United States

About this study

Test the effectiveness of SFA adapted for the substance use outreach workforce compared to a no treatment control condition on social-support and burnout of HRWs in a cluster-randomized hybrid type I trial.

Read the detailed description

Alongside prevention, treatment, and supply reduction, outreach work is a cornerstone of the National Drug Control Strategy. However, there is a critical gap in research on the occupational health of substance use outreach workers, who are exposed to high rates of lifetime and occupational stress and trauma. High rates of unaddressed occupational stress have been shown to have an adverse impact on patient care and are linked to unmet mental health needs, turnover, burnout, and relapse. The substance use outreach workforce needs an occupational stress intervention program that addresses both systems and individual occupational challenges while promoting the capacity to engage with the complex demands of delivering safe high-quality substance use care to people who use drugs (PWUD).

Stress First Aid is a promising intervention that has been implemented with several first responder groups and in healthcare settings, but it requires adaptation to the substance use outreach workforce and it needs to be studied against a control group in a rigorous clinical trial. In the R61 planning phase of this study, focus groups comprised of workers and leaders from organizations doing substance use outreach work were convened to adapt the SFA training content and to inform the SFA training delivery methods that were piloted in a field test (N = 35). Findings were integrated into a clinical trial protocol.

In the R33 phase of this study, we will conduct a cluster-randomized hybrid type I trial (N = 500) testing the effectiveness of participation in a 2-hour virtual SFA training and six 30-minute monthly learning collaboratives compared to a no treatment control condition on the following primary outcomes: supervisor and coworker support and burnout. Secondary outcomes are use of SFA concepts, job related affective well-being, secondary traumatic stress, coping strategies, self-efficacy, work engagement, turnover intention, and moral injury symptoms. The long-term goal of our work is to implement a sustainable and effective occupational stress intervention for the substance use outreach workforce nationally in order to strengthen their important role in the substance misuse work force.

Being tested
Stress First Aid (SFA)
Keywords
Stress First Aid, Persons who use drugs, overdose prevention, community outreach workers, substance use outreach workers

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Stress First Aid (SFA)Behavioural

    Stress First Aid for the Substance Use Outreach Workforce is a 2-hour training and up to six virtual 30-minute monthly learning collaborative meetings.

Study groups in NCT07177014
Study groupRoleWhat they receive
No TreatmentNo interventionControl: No Treatment
Stress First Aid (SFA)ExperimentalTreatment group receives Stress First Aid for the Substance Use Outreach Workforce, a 2-hour training and up to six virtual 30-minute monthly learning collaborative meetings.
Receives: Behavioral: Stress First Aid (SFA)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in the Mean Overall Burnout Assessed by the Copenhagen Burnout Inventory at 2 Months

    A 19-item, 5-point Likert type scale, where a higher score is a worse outcome. Minimum score of 0, maximum score of 100.

    Measured: From enrollment to 2 months after the intervention training

  2. Change from Baseline in the Mean Overall Social Support Assessed by the Job Content Questionnaire Social Support Sub-Scale at 2 Months

    An 8-item; 4-point Likert-type scale, where a higher score is a better outcome. Minimum score of 8, maximum score of 40.

    Measured: From enrollment to 2 months after the intervention training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2025
  2. Study start5 Dec 2025
  3. Primary completion28 Feb 2029 (estimated)
  4. Study completion28 Feb 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Cluster-randomized hybrid type I trial of SFA adapted for the substance use outreach workforce compared to a no treatment control condition.
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07177014
Sponsor's protocol ID
STUDY00008024
Acronym
SFA-Impact
Status last verified
Feb 2026
First submitted
9 Sep 2025
Last updated
3 Mar 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Desai A, McCormick KA, Rau J, Rochani H, Chang P, Westphal RJ, Watson PJ, Claborn KR, Benzer JK, Creech SK. Impact and implementation evaluation of Stress First Aid for the Substance Use Outreach Workforce (SFA/SUOW): protocol of a hybrid type I cluster randomized control trial. Trials. 2026 Jun 20. doi: 10.1186/s13063-026-09856-4. Online ahead of print.

    PubMed 42323672

Questions about this trial

What is this clinical trial studying?

A study testing Stress First Aid (SFA) in people with Occupational Health, run by University of Texas at Austin at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Project Coordinator (512-495-5277, SFA@austin.utexas.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in the Mean Overall Burnout Assessed by the Copenhagen Burnout Inventory at 2 Months (time frame: From enrollment to 2 months after the intervention training). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07177014, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in